Stocks · Health care · Biological Products, (No Diagnostic Substances)

4D Molecular Therapeutics, Inc.

FDMT Clue Score62
United States Fiscal year ends December CIK 0001650648 Results filed 13 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
David Kirn
5 Oct 2026
See Remarks
Sold on a plan
272
$13.61
$3.70K
David Kirn
5 Oct 2026
See Remarks
Sold on a plan
58,061
$12.92
$750.24K
David Kirn
14 Sep 2026
See Remarks
Sold on a plan
58,333
$13.90
$811.00K
David Kirn
4 Aug 2026
See Remarks
Sold on a plan
26,842
$10.23
$274.60K
David Kirn
3 Aug 2026
See Remarks
Sold on a plan
12,415
$10.05
$124.72K
David Kirn
10 Jul 2026
See Remarks
Sold on a plan
442
$12.84
$5.67K
David Kirn
10 Jul 2026
See Remarks
Sold on a plan
15,283
$12.01
$183.56K
David Kirn
9 Jul 2026
See Remarks
Sold on a plan
42,608
$12.87
$548.18K
David Kirn
22 Jun 2026
See Remarks
Sold on a plan
114,746
$10.47
$1.20M
David Kirn
1 Jun 2026
See Remarks
Sold on a plan
1,922
$10.02
$19.26K
Scott Bizily
9 Oct 2025
Chief Legal Officer
Sold on a plan
2,408
$10.00
$24.08K
Scott Bizily
23 Sep 2025
Chief Legal Officer
Sold on a plan
2,407
$8.00
$19.26K
David Kirn
8 Feb 2024
Chief Executive Officer
Sold on a plan
92,001
$27.13
$2.50M
David Kirn
5 Jan 2024
Chief Executive Officer
Sold on a plan
133
$20.11
$2.67K
David Kirn
5 Jan 2024
Chief Executive Officer
Sold on a plan
28,104
$19.56
$549.80K
David Kirn
4 Jan 2024
Chief Executive Officer
Sold on a plan
40,732
$20.31
$827.20K
David Kirn
18 Dec 2023
Chief Executive Officer
Sold on a plan
4,702
$18.13
$85.24K
David Kirn
15 Dec 2023
Chief Executive Officer
Sold on a plan
28,632
$17.27
$494.43K

What was left out

Form 4 filings counted 142
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 18
Sales straight out of an exercise 54
Sales at will 24
Transactions with no price 0
Shares from compensation/vesting 11,101,263
Sales filed before the plan box existed 22
History held since 17 Dec 2020